The Blood Pressure Breakthrough: Mineralys Therapeutics’ Lorundrostat Shows Promise in Treating Uncontrolled Hypertension

In a major breakthrough for the medical community, Mineralys Therapeutics has announced positive topline results from…

Mineralys Therapeutics: Lorundrostat Is Worth A Shot In 2025 For Hypertension

Mineralys Therapeutics: Lorundrostat Is Worth A Shot In 2025 For Hypertension #Mineralys #Therapeutics #Lorundrostat #Worth #Shot…

Recor Medical Statement on CMS National Coverage Analysis of Renal Denervation for the Treatment of Hypertension By Investing.com

Palo Alto, CA, Jan. 13, 2025 (GLOBE NEWSWIRE) — Recor Medical (TASE:), Inc. (Recor) and its…